NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients

CompletedN/A

Sponsor: Central Hospital, Nancy, France

Conditions: Presence of COVID-19 Compatible CT Abnormalities

Interventions: PET-CT of 18F-FDG

Countries: France

CT signs that are evocative of lung COVID-19 infections have been extensively described, whereas 18F-FDG-PET signs have not. Our current study aimed to identify specific COVID-19 18F-FDG-PET signs in patients that were (i) suspected to have a lung infection based on 18F-FDG-PET/CT recorded during the COVID-19 outbreak and (ii) whose COVID-19 diagnosis was definitely established or excluded by appropriate viral testing.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patient coming to nuclear medicine for 18F-flurodesoxyglucose (FDG) positron emission tomography computed tomography (PET-CT) with suspicion of lung involvement
* patient affiliated to a social security scheme or equivalent
* adult patient having been informed of the study

Exclusion Criteria:

* patient with a negative covid 19 test

Locations (1)

Vandœuvre-lès-Nancy, Grand Est, France